Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database
leading to pneumonitis with a poor prognosis. Tocilizumab, a type of humanized monoclonal antibody antagonizing interleukin-6 receptors, is currently utilized to treat COVID-19. The present study reviews tocilizumab adverse drug events (ADEs) reported in the World Health Organization (WHO) pharmacov...
Saved in:
Main Authors: | Charan, Jaykaran, Dutta, Siddhartha, Kaur, Rimplejeet, Bhardwaj, Pankaj, Sharma, Parveen, Ambwani, Sneha, Jahan, Iffat, Abubakar, Abdullahi Rabiu, Islam, Salequl, Hardcastle, Timothy Craig, A. Rahman, Nor Azlina, Lugova, Halyna, Haque, Mainul |
---|---|
Format: | Article |
Language: | English English |
Published: |
Taylor & Francis
2021
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/93893/7/93893_Tocilizumab%20in%20COVID-19%20a%20study%20of%20adverse%20drug_SCOPUS.pdf http://irep.iium.edu.my/93893/8/93893_Tocilizumab%20in%20COVID-19%20a%20study%20of%20adverse%20drug.pdf http://irep.iium.edu.my/93893/ https://www.tandfonline.com/toc/ieds20/current https://doi.org/10.1080/14740338.2021.1946513 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Terminated interventional trials in the clinical trial registry of India database: an analysis to evaluate the reasons for termination
by: Dutta, Siddhartha, et al.
Published: (2020) -
Perception of Nigerian medical students on adverse drug reaction reporting
by: Mainul, Haque, et al.
Published: (2015) -
Adverse Drug Reactions: Predisposing Factors, Modern Classifications and Causality Assessment
by: Mainul, Haque, et al.
Published: (2014) -
A systematic review of knowledge, attitude and practice on adverse drug reactions and pharmacovigilance among doctors
by: Mainul, Haque, et al.
Published: (2014) -
Chemical profile, total phenolic content, DPPH free radical scavenging and α-glucosidase inhibitory activities of cosmos caudatus kunth leaves
by: Wan Ahmad, Wan Nadilah, et al.
Published: (2018)